We are live on ! Find out more
Los Angeles Capital Management

Los Angeles Capital Management Portfolio holdings

AUM $25.4B
1-Year Est. Return 38.46%
This Fund
S&P 500
This Quarter Est. Return
+16.76%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$29.3B
AUM Growth
+$2.52B
Cap. Flow
-$813M
Cap. Flow %
-2.78%
Top 10 Hldgs %
34.45%
Holding
1,250
New
131
Increased
366
Reduced
518
Closed
126

Top Buys

Rank Stock Value
1
NTAP icon
NetApp
NTAP
+$153M
2
AMZN icon
Amazon
AMZN
+$147M
3
NFLX icon
Netflix
NFLX
+$125M
4
C icon
Citigroup
C
+$107M
5
ULTA icon
Ulta Beauty
ULTA
+$95.1M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$267M
2
TSLA icon
Tesla
TSLA
+$157M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$140M
4
V icon
Visa
V
+$113M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$109M

Sector Composition

Rank Sector Weight
1 Technology 33.22%
2 Consumer Discretionary 14.97%
3 Financials 13.47%
4 Industrials 11.61%
5 Communication Services 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AL
1126
DELISTED
Air Lease Corp
AL
-5,052
Closed -$212K
GOLD
1127
Gold.com Inc
GOLD
$1.29B
-33,529
Closed -$1.01M
ASPN icon
1128
Aspen Aerogels
ASPN
$505M
-28,626
Closed -$452K
ATI icon
1129
ATI
ATI
$31.1B
-7,592
Closed -$345K
AVB icon
1130
AvalonBay Communities
AVB
$26.3B
-1,308
Closed -$245K
AVT icon
1131
Avnet
AVT
$7.93B
-500,608
Closed -$25.2M
BAX icon
1132
Baxter International
BAX
$14.2B
-60,266
Closed -$2.33M
BBIO icon
1133
BridgeBio Pharma
BBIO
$16.2B
-9,436
Closed -$381K
BMRN icon
1134
BioMarin Pharmaceuticals
BMRN
$13.4B
-6,911
Closed -$666K
BRY
1135
DELISTED
Berry Corp
BRY
-132,036
Closed -$928K
BY icon
1136
Byline Bancorp
BY
$1.79B
-24,330
Closed -$573K
CALX icon
1137
Calix
CALX
$2.56B
-7,656
Closed -$334K
CBZ icon
1138
CBIZ
CBZ
$2.97B
-10,441
Closed -$654K
CCEP icon
1139
Coca-Cola Europacific Partners
CCEP
$47.3B
-4,053
Closed -$270K
CCL icon
1140
Carnival Corporation Ltd
CCL
$38.9B
-63,693
Closed -$1.18M
CCK icon
1141
Crown Holdings
CCK
$13.1B
-22,051
Closed -$2.03M
CCOI icon
1142
Cogent Communications
CCOI
$496M
-24,530
Closed -$1.87M
CHRD icon
1143
Chord Energy
CHRD
$7.3B
-19,621
Closed -$3.26M
CHTR icon
1144
Charter Communications
CHTR
$18.3B
-533
Closed -$207K
CIEN icon
1145
Ciena
CIEN
$63.7B
-68,956
Closed -$3.1M
CMA
1146
DELISTED
Comerica
CMA
-108,763
Closed -$6.07M
CNK icon
1147
Cinemark Holdings
CNK
$4.4B
-58,368
Closed -$822K
COHR icon
1148
Coherent
COHR
$69.1B
-10,021
Closed -$436K
COO icon
1149
Cooper Companies
COO
$15.1B
-5,516
Closed -$522K
CRC icon
1150
California Resources
CRC
$4.65B
-8,873
Closed -$485K

Similar funds

Los Angeles Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Los Angeles Capital Management held 1,250 positions worth $29.3B, up 9.4% from $26.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Los Angeles Capital Management's Q1 2024 filing shows 131 new, 366 increased, 518 reduced and 126 closed positions. Its largest new stake was Armstrong World Industries: 315,435 shares worth $39.2M. The largest sale was Amgen, an estimated $267M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Los Angeles Capital Management's largest Q1 2024 buy was Armstrong World Industries: 315,435 shares worth $39.2M.
  • Los Angeles Capital Management added most to NetApp in Q1 2024, an estimated $153M increase.
  • Los Angeles Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $267M.
  • Los Angeles Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $28.2M.
  • Los Angeles Capital Management's ten largest holdings make up 34% of its $29.3B portfolio in Q1 2024.
  • Los Angeles Capital Management opened 131 new positions and closed 126 in Q1 2024.
  • Los Angeles Capital Management's portfolio value rose 9.4% quarter-over-quarter to $29.3B.

Based on Los Angeles Capital Management's 13F filing for Q1 2024, filed 5 Apr 2024.